Objectives: Hypoglycemia is a common adverse event for people with type 1 and type 2 diabetes mellitus. In this article, we explore the specific roles that individuals assume to prevent or treat hypoglycemia. Methods: A descriptive qualitative study from the UnderstandINg the impact of HYPOglycemia on Diabetes Management Study (InHypo-DM) research program. A purposive sample of people with type 1 and type 2 diabetes were recruited for semistructured interviews. There were 16 participants (women and men), who were, on average, 53 years old. Average time since diagnosis was 15 (type 1) and 21 (type 2) years; all patients had at least 1 hypoglycemic event in the past year. Individual and team analysis of interviews were conducted to identify o...
Objective: Hypoglycemia can cause psychological distress in people with diabetes; however, less is u...
Aim: To synthesise the evidence on how community‐dwelling adults with type 1 and type 2 diabetes mel...
Introduction Achieving glycemic targets and optimizing quality of life (QoL) are important goals of ...
Abstract Background Hypoglycaemia is a common and potentially avoidable adverse event in people with...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
Hegney, DG ORCiD: 0000-0003-1267-1760BACKGROUND: Hypoglycaemia, a common complication of diabetes dr...
BACKGROUND: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to infl...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
IntroductionAchieving glycemic targets and optimizing quality of life (QoL) are important goals of t...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
Background: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to inf...
Objective: Hypoglycemia can cause psychological distress in people with diabetes; however, less is u...
Aim: To synthesise the evidence on how community‐dwelling adults with type 1 and type 2 diabetes mel...
Introduction Achieving glycemic targets and optimizing quality of life (QoL) are important goals of ...
Abstract Background Hypoglycaemia is a common and potentially avoidable adverse event in people with...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
Hegney, DG ORCiD: 0000-0003-1267-1760BACKGROUND: Hypoglycaemia, a common complication of diabetes dr...
BACKGROUND: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to infl...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
IntroductionAchieving glycemic targets and optimizing quality of life (QoL) are important goals of t...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
Background: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to inf...
Objective: Hypoglycemia can cause psychological distress in people with diabetes; however, less is u...
Aim: To synthesise the evidence on how community‐dwelling adults with type 1 and type 2 diabetes mel...
Introduction Achieving glycemic targets and optimizing quality of life (QoL) are important goals of ...